Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
RESEARCH TOOLSreports
SBTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range8.32p - 26.45p
Previous CloseN/A
Volume282.34K
Average Volume (3M)1.51M
Market Cap
£45.14M
Enterprise Value41.05M
Total Cash (Recent Filing)£2.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Dec 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding232,975,390
10 Day Avg. Volume2,362,361
30 Day Avg. Volume1,508,241
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)318.19
Price to Cash Flow (P/CF)-18.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
SkinBioTherapeutics News
PremiumCompany Announcements
SkinBioTherapeutics and Croda Unveil Zenakine™ at Global Cosmetics Event
PremiumCompany Announcements
SkinBioTherapeutics Announces Change in Major Shareholdings
PremiumCompany Announcements
SkinBioTherapeutics Announces Warrant Exercise and Share Increase
PremiumCompany Announcements
SkinBioTherapeutics Expands Share Capital with Warrant Exercise
PremiumCompany Announcements
SkinBioTherapeutics Announces Change in Voting RightsPremiumCompany Announcements
SkinBioTherapeutics Reduces Debt via Warrant Exercise Post Acquisition---
SBTX FAQ
What was SkinBioTherapeutics PLC’s price range in the past 12 months?
SkinBioTherapeutics PLC lowest share price was 8.32p and its highest was 26.45p in the past 12 months.
What is SkinBioTherapeutics PLC’s market cap?
SkinBioTherapeutics PLC’s market cap is £45.14M.
When is SkinBioTherapeutics PLC’s upcoming earnings report date?
SkinBioTherapeutics PLC’s upcoming earnings report date is Dec 04, 2025 which is in 236 days.
How were SkinBioTherapeutics PLC’s earnings last quarter?
SkinBioTherapeutics PLC released its earnings results on Mar 26, 2025. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of N/A by -0.005p.
Is SkinBioTherapeutics PLC overvalued?
According to Wall Street analysts SkinBioTherapeutics PLC’s price is currently Overvalued.
Does SkinBioTherapeutics PLC pay dividends?
SkinBioTherapeutics PLC does not currently pay dividends.
What is SkinBioTherapeutics PLC’s EPS estimate?
SkinBioTherapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics PLC have?
SkinBioTherapeutics PLC has 232,975,390 shares outstanding.
What happened to SkinBioTherapeutics PLC’s price movement after its last earnings report?
SkinBioTherapeutics PLC reported an EPS of -0.005p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of SkinBioTherapeutics PLC?
Currently, no hedge funds are holding shares in GB:SBTX
---
SkinBioTherapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
92.50%
12-Months-Change
Fundamentals
Return on Equity
-63.28%
Trailing 12-Months
Asset Growth
73.26%
Trailing 12-Months
Company Description
SkinBioTherapeutics PLC
SkinBioTherapeutics (SBTX) is a life sciences company based in the United Kingdom, specializing in the development of technology derived from the human microbiome for the treatment and prevention of skin conditions. The company focuses on utilizing its proprietary SkinBiotix technology platform to create products that enhance skin health by harnessing the beneficial properties of specific probiotic bacteria.
---
Technical Analysis
---